BCR and prostate cancer: [68 Ga]Ga-PSMA-11 and [18F]F-DCFPyL PET/CT demonstrated high patient- and region-level detection rates and positive predictive value for the localization of prostate cancer in the setting of BCR or BCP [33–35].